314 related articles for article (PubMed ID: 2655909)
1. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial.
Maroko PR; McDevitt JT; Fox MJ; Silber SA; Young MD; Beg M; Rockhold FW; Free SM; Herron JR; Gray JM
Clin Ther; 1989; 11(1):94-119. PubMed ID: 2655909
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
Weir MR; Lavin PT; Byrnes CA
Clin Ther; 1993; 15(3):527-38. PubMed ID: 8364944
[TBL] [Abstract][Full Text] [Related]
4. Propranolol-hydrochlorothiazide combination in essential hypertension.
Stevens JD; Mullane JF
Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
[TBL] [Abstract][Full Text] [Related]
5. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
[TBL] [Abstract][Full Text] [Related]
7. Losartan with hydrochlorothiazide in the treatment of hypertension.
Schoenberger JA;
J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
[TBL] [Abstract][Full Text] [Related]
8. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients.
Böhm M; Ewald S;
Curr Med Res Opin; 2006 Jul; 22(7):1375-80. PubMed ID: 16834836
[TBL] [Abstract][Full Text] [Related]
10. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.
Creisson C; Baulac L; Lenfant B
Postgrad Med J; 1986; 62 Suppl 1():139-41. PubMed ID: 3534849
[TBL] [Abstract][Full Text] [Related]
11. Step-one antihypertensive therapy: a comparison of a centrally acting agent and a diuretic.
McCarron DA
J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S853-8. PubMed ID: 6084139
[TBL] [Abstract][Full Text] [Related]
12. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
13. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA; Punzi CF
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
[TBL] [Abstract][Full Text] [Related]
15. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
16. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
Woo J; Woo KS; Kin T; Vallance-Owen J
Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of mild and moderate hypertension with the use of captopril alone or combined with hydrochlorothiazide. A multicenter study].
Nascimento LO; Lion R; Lion MF; Pesquisadores E
Arq Bras Cardiol; 1989 Sep; 53(3):177-83. PubMed ID: 2698133
[TBL] [Abstract][Full Text] [Related]
18. Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension.
Keinänen-Kiukaanniemi S; Rasmusen M; Pekkarinen T; Pitkäjärvi T; Romo M; Takala J
Arzneimittelforschung; 1997 Feb; 47(2):144-50. PubMed ID: 9079233
[TBL] [Abstract][Full Text] [Related]
19. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
